{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T01:06:08Z","timestamp":1762045568975,"version":"build-2065373602"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T00:00:00Z","timestamp":1636675200000},"content-version":"vor","delay-in-days":72,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nefrolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.nefroe.2021.11.008","type":"journal-article","created":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T16:28:07Z","timestamp":1640190487000},"page":"502-513","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Monoclonal gammopathy of renal significance: Early diagnosis is key"],"prefix":"10.1016","volume":"41","author":[{"given":"Juana","family":"Alonso-Titos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Dolores","family":"Mart\u00ednez-Esteban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ver\u00f3nica","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myriam","family":"Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo","family":"Martin-Reyes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Ruiz-Esteban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domingo","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nefroe.2021.11.008_bib0170","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41581-018-0077-4","article-title":"The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group","volume":"15","author":"Leung","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.nefroe.2021.11.008_bib0175","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0272-6386(12)80314-3","article-title":"Long-term follow-up and response to chemotherapy in patients with light-chain deposition disease","volume":"20","author":"Heilman","year":"1992","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nefroe.2021.11.008_bib0180","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.18632\/oncotarget.23412","article-title":"Monoclonal gammopathy of renal significance (MGRS) increases the risk for progression to multiple myeloma: an observational study of 2935 MGUS patients","volume":"9","author":"Steiner","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.nefroe.2021.11.008_bib0185","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.nefro.2017.03.012","article-title":"Monoclonal gammopathies of renal significance","volume":"37","author":"Caravaca-Font\u00e1n","year":"2017","journal-title":"Nefrologia"},{"key":"10.1016\/j.nefroe.2021.11.008_bib0190","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.nefroe.2021.11.008_bib0195","first-page":"15","article-title":"The value of serum free light chain assay in patients with monoclonal gammopathies and renal failure","volume":"32","author":"Campos","year":"2012","journal-title":"Nefrologia"},{"key":"10.1016\/j.nefroe.2021.11.008_bib0200","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1681\/ASN.2017121319","article-title":"The complexity and heterogeneity of monoclonal immunoglobulin-associated renal diseases","volume":"29","author":"Sethi","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2021.11.008_bib0205","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5527\/wjn.v6.i2.72","article-title":"Monoclonal gammopathy of renal significance: diagnostic workup","volume":"6","author":"Correia","year":"2017","journal-title":"World J Nephrol"},{"key":"10.1016\/j.nefroe.2021.11.008_bib0210","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1182\/bloodadvances.2019031914","article-title":"Pathophysiology and management of monoclonal gammopathy of renal significance","volume":"3","author":"Jain","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.nefroe.2021.11.008_bib0215","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-018-0080-9","article-title":"Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2018","volume":"8","author":"Gertz","year":"2018","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.nefroe.2021.11.008_bib0220","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.2215\/CJN.03160316","article-title":"Bridging the divide: an onco-nephrologic approach to the monoclonal gammopathies of renal significance","volume":"11","author":"Hogan","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2021.11.008_bib0225","doi-asserted-by":"crossref","first-page":"128","DOI":"10.2215\/CJN.00560117","article-title":"Dysproteinemias and glomerular disease","volume":"13","author":"Leung","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2021.11.008_bib0230","doi-asserted-by":"crossref","DOI":"10.1186\/s12882-018-0927-0","article-title":"C3 glomerulonephritis associated with monoclonal gammopathy of renal significance: case report","volume":"19","author":"Alonso-Titos","year":"2018","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.nefroe.2021.11.008_bib0235","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1681\/ASN.2012060577","article-title":"Recurrent membranous nephropathy in an allograft caused by IgG3k targeting the PLA2 receptor","volume":"23","author":"Debiec","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2021.11.008_bib0240","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1053\/j.ajkd.2006.01.004","article-title":"Marked recovery of severe renal lesions in POEMS syndrome with high-dose melphalan therapy supported by autologous blood stem cell transplantation","volume":"47","author":"Sanada","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nefroe.2021.11.008_bib0245","doi-asserted-by":"crossref","DOI":"10.1007\/s11255-019-02131-3","article-title":"Why renal biopsy is crucial in monoclonal gammopathy of renal significance (MGRS)","volume":"51","author":"Ciocchini","year":"2019","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.nefroe.2021.11.008_bib0250","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1681\/ASN.V1271482","article-title":"Renal monoclonal immunoglobulin deposition disease: the disease spectrum","volume":"12","author":"Lin","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2021.11.008_bib0255","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20190206","article-title":"Activin A: a novel urinary biomarker of renal impairment in multiple myeloma","volume":"39","author":"Iriuchishima","year":"2019","journal-title":"Biosci Rep"},{"key":"10.1016\/j.nefroe.2021.11.008_bib0260","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s00277-018-3572-6","article-title":"Bortezomib-based chemotherapy can improve renal and tubular functions in patients with light chain-associated Fanconi syndrome","volume":"98","author":"Wu","year":"2019","journal-title":"Ann Hematol"},{"key":"10.1016\/j.nefroe.2021.11.008_bib0265","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1182\/blood-2013-05-495929","article-title":"How I treat monoclonal gammopathy of renal significance (MGRS)","volume":"122","author":"Fermand","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.nefroe.2021.11.008_bib0270","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1272\/jnms.JNMS.2019_86-1","article-title":"Monoclonal immunoglobulin deposition disease related diseases","volume":"86","author":"Kanzaki","year":"2019","journal-title":"Nippon Med J Sch"},{"key":"10.1016\/j.nefroe.2021.11.008_bib0275","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1182\/blood-2018-09-872028","article-title":"Randall-type monoclonal immunoglobulin deposition disease: novel insights from a nationwide cohort study","volume":"133","author":"Joly","year":"2019","journal-title":"Blood"},{"issue":"October","key":"10.1016\/j.nefroe.2021.11.008_bib0280","article-title":"Both monoclonal and polyclonal immunoglobulin contingents mediate complement activation in monoclonal gammopathy associated-C3 glomerulopathy","volume":"9","author":"Chauvet","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.nefroe.2021.11.008_bib0285","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/ki.2014.408","article-title":"Diagnosis of monoclonal gammopathy of renal significance","volume":"87","author":"Bridoux","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefroe.2021.11.008_bib0290","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1016\/j.transproceed.2009.03.100","article-title":"Case of recurrent immunotactoid glomerulopathy in an allograft treated with rituximab","volume":"41","author":"Sathyan","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.nefroe.2021.11.008_bib0295","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1182\/blood-2012-07-445304","article-title":"Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant","volume":"120","author":"Leung","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.nefroe.2021.11.008_bib0300","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1182\/blood-2006-09-046409","article-title":"Activity and safety of bortezomib in multiple myeloma patients with advanced renal failure: a multicenter retrospective study","volume":"109","author":"Chanan-Khan","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.nefroe.2021.11.008_bib0305","doi-asserted-by":"crossref","first-page":"e207","DOI":"10.3324\/haematol.2014.118182","article-title":"Subcutaneous versus intravenous bortezomib in patients with relapsed multiple myeloma: subanalysis of patients with renal impairment in the phase iii MMY-3021 study","volume":"100","author":"Moreau","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.nefroe.2021.11.008_bib0310","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1182\/blood-2018-04-839480","article-title":"Monoclonal gammopathy of clinical significance: a novel concept with therapeutic implications","volume":"132","author":"Fermand","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.nefroe.2021.11.008_bib0315","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/bjh.15116","article-title":"Investigational agents in immunotherapy: a new horizon for the treatment of multiple myeloma","volume":"181","author":"Varga","year":"2018","journal-title":"Br J Haematol"},{"issue":"12.","key":"10.1016\/j.nefroe.2021.11.008_bib0320","article-title":"Monoclonal antibodies for the treatment of multiple myeloma: an update","volume":"19","author":"Abramson","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"March","key":"10.1016\/j.nefroe.2021.11.008_bib0325","article-title":"Immunogenic cell death and immunotherapy of multiple myeloma","volume":"7","author":"Serrano-del Valle","year":"2019","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.nefroe.2021.11.008_bib0330","article-title":"Therapeutic monoclonal antibodies and antibody products: current practices and development in multiple myeloma","volume":"12","author":"Bonello","year":"2020","journal-title":"Cancers (Basel)"}],"container-title":["Nefrolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2013251421001140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2013251421001140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T19:46:30Z","timestamp":1761853590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2013251421001140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S2013251421001140"],"URL":"https:\/\/doi.org\/10.1016\/j.nefroe.2021.11.008","relation":{},"ISSN":["2013-2514"],"issn-type":[{"type":"print","value":"2013-2514"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monoclonal gammopathy of renal significance: Early diagnosis is key","name":"articletitle","label":"Article Title"},{"value":"Nefrolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nefroe.2021.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Sociedad Espa\u00f1ola de Nefrolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}